Dr Earl J Snyder, MD | |
525 Westpark Dr, Suite 100, Peachtree City, GA 30269-1575 | |
(770) 487-0029 | |
(770) 692-0116 |
Full Name | Dr Earl J Snyder |
---|---|
Gender | Male |
Speciality | Pain Medicine - Pain Medicine |
Location | 525 Westpark Dr, Peachtree City, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538374376 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 055703 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Earl J Snyder, MD 525 Westpark Dr, Suite 100, Peachtree City, GA 30269-1575 Ph: (770) 487-0029 | Dr Earl J Snyder, MD 525 Westpark Dr, Suite 100, Peachtree City, GA 30269-1575 Ph: (770) 487-0029 |
News Archive
One way to defeat an opponent is to cut off its supply lines. Tumors are no different. The supply lines for tumors are the blood vessels that ferry oxygen and nutrients to the cells. Restricting the blood vessels that feed tumor cells can shrink the tumor. A cross-institutional international team of scientists recently discovered a new, important step of the process that grows new blood vessels, a discovery that could lead to a new way to combat cancer.
Researchers from the University at Buffalo at The State University of New York examined the effects of pre-existing post traumatic stress disorder (PTSD) on mechanically ventilated veterans during ICU hospitalization. This retrospective cohort study found that mechanically ventilated patients with PTSD had higher sedation requirements.
Researchers at Vanderbilt University Medical Center are leading a study designed to identify early drivers of pulmonary fibrosis in an at-risk patient population. Funding for the research, which could help predict early disease at the cellular level and possibly drive the development of novel therapies, is being provided by Three Lakes Foundation.
Mylan Inc. today commented on a ruling for partial summary judgment in its patent infringement lawsuit against Sunovion Pharmaceuticals Inc. in relation to Sunovion's Brovana product.
› Verified 6 days ago